Canada markets close in 4 hours 16 minutes

Amarin Corporation plc (AMRN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.7899+0.0699 (+9.71%)
As of 11:44AM EST. Market open.

Amarin Corporation plc

Iconic Offices, The Greenway
Block C Ardilaun Court St Stephens Green
Dublin 112-114
353 0 166 99020

IndustryDrug Manufacturers - General
Full Time Employees365

Key Executives

NameTitlePayExercisedYear Born
Mr. Thomas Charles ReillyChief Financial Officer856.49kN/A1972
Dr. Steven B. Ketchum Ph.D.President of Research & Development and Chief Scientific Officer991.19kN/A1965
Mr. Aaron D. BergExecutive VP & President of U.S.913.7kN/A1963
Mr. Patrick HoltPresident, CEO & DirectorN/AN/AN/A
Mr. Jordan ZwickSenior VP of Corporate Business Development & Investor RelationsN/AN/A1987
Mr. Jonathan N. ProvoostExecutive VP and Chief Legal & Compliance OfficerN/AN/AN/A
Ms. Donna PasekSenior Vice President of Human ResourcesN/AN/AN/A
Mr. Laurent AbuafPresident of Europe & Senior VPN/AN/AN/A
Dr. Nabil AbadirChief Medical Officer of Global Medical AffairsN/AN/AN/A
Dr. David Keenan Ph.D.Executive VP of Technical Operations & President of EuropeN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Corporate Governance

Amarin Corporation plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.